Average Co-Inventor Count = 2.98
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nivalis Therapeutics, Inc. (19 from 19 patents)
2. N30 Pharmaceuticals, Inc. (15 from 17 patents)
3. Crestone, Inc. (2 from 7 patents)
4. Replidyne, Inc. (1 from 12 patents)
5. Laurel Therapeutics Ltd. (1 from 1 patent)
38 patents:
1. 10399946 - Solid forms of an S-Nitrosoglutathione reductase inhibitor
2. 9856219 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
3. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
4. 9717706 - Chromone inhibitors of S-nitrosoglutathione reductase
5. 9707212 - S-nitrosoglutathione reductase inhibitors
6. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
7. 9433618 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
8. 9364481 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
9. 9315462 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
10. 9283213 - [object Object]
11. 9283229 - [object Object]
12. 9249132 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
13. 9221810 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
14. 9187447 - S-nitrosoglutathione reductase inhibitors
15. 9180119 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents